Clinical Trial Update: Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pyruvate in patients with cardiogenic shock supported by intra-aortic balloon counterpulsation has completed; results are not detailed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Heart Failure
• Myocardial Infarction

Drugs mentioned

• Pyruvate (Pyruvate)

Snippet

Sponsor: Herzzentrum Goettingen | Conditions: Shock, Cardiogenic, Heart Failure | Phase 2 | Status: COMPLETED